Radiotherapy in small cell lung cancer: Limited volumes in limited disease and adding thoracic radiotherapy in extended disease?

Radiotherapy and Oncology

Volumn 102, Issue 2, 2012, Pages 165-167

  Kepka, Lucyna ^a   Baumann, Michael ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RADIOTHERAPY; DISEASE SEVERITY; HUMAN; LUNG SMALL CELL CANCER; PRIORITY JOURNAL; REVIEW; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 84857633857     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2012.01.001     Document Type: Editorial

References (62)

1. M. Baumann, D. Zips, and S. Appold Radiotherapy of lung cancer: technology meets biology meets multidisciplinarity Radiother Oncol 91 2009 279 281
2. T. Le Chevalier, R. Arriagada, and E. Quoix Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients J Natl Cancer Inst 83 1991 417 423
3. M. Saunders, S. Dische, A. Barrett, A. Harvey, G. Griffiths, and M. Palmar Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomized multicenter trial Radiother Oncol 52 1999 137 148
4. M. Baumann, T. Herrmann, and R. Koch Final results of the randomized phase III CHARTWEL-trial (ARO 97-1) comparing hyperfractionated-accelerated versus conventionally fractionated radiotherapy in non-small cell lung cancer (NSCLC) Radiother Oncol 100 2011 76 85
5. D. De Ruysscher, W. van Elmpt, and P. Lambin Radiotherapy with curative intent for lung cancer: a continuing success story Radiother Oncol 101 2011 237 239
6. C. Gillham, D. Zips, and F. Ponisch Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning? Radiother Oncol 88 2008 335 341
7. M. MacManus, U. Nestle, and K.E. Rosenzweig Use of PET and PET/CT for radiation therapy planning: IAEA expert report 2006-2007 Radiother Oncol 91 2009 85 94
8. J. Van Loon, C. Offermann, and M. Ollers Early CT and FDG-metabolic tumour volume changes show a significant correlation with survival in stage I-III small cell lung cancer: a hypothesis generating study Radiother Oncol 99 2011 172 175
9. J. Van Loon, A. van Baardwijk, L. Boersma, M. Ollers, P. Lambin, and D. De Ruysscher Therapeutic implications of molecular imaging with PET in the combined modality treatment of lung cancer Cancer Treat Rev 37 2011 331 343
10. M. Guckenberger, J. Wibert, A. Richter, K. Baier, and M. Flentje Potential of adaptive radiotherapy to escalate the radiation dose in combined radiochemotherapy for locally advanced non-small cell lung cancer Int J Radiat Oncol Biol Phys 79 2011 901 908
11. R. Perrin, P.M. Evans, S. Webb, and M. Partridge The use of PET images for radiotherapy treatment planning: an error analysis using radiobiological endpoints Med Phys 37 2010 516 531
12. A. Takeda, N. Yokosuka, and T. Ohashi The maximum standardized uptake value (SUVmax) on FDG-PET is a strong predictor of local recurrence for localized non-small-cell lung cancer after stereotactic radiotherapy (SBRT) Radiother Oncol 101 2011 291 297
13. S.J. Kim, Y.K. Kim, I.J. Kim, Y.D. Kim, and M.K. Lee Limited prognostic value of dual time point F-18 FDG PET/CT in patients with early stage (stage I & II) non-small cell lung cancer (NSCLC) Radiother Oncol 98 2011 105 108
14. M. Wanet, J.A. Lee, and B. Weynand Gradient-based delineation of the primary GTV on FDG-PET in non-small cell lung cancer: a comparison with threshold-based approaches, CT and surgical specimens Radiother Oncol 98 2011 117 125
15. S. Gaede, J. Olsthoorn, and A.V. Louie An evaluation of an automated 4D-CT contour propagation tool to define an internal gross tumour volume for lung cancer radiotherapy Radiother Oncol 101 2011 322 328
16. G. Meijer, J. Steenhuijsen, M. Bal, K. De Jaeger, D. Schuring, and J. Theuws Dose painting by contours versus dose painting by numbers for stage II/III lung cancer: practical implications of using a broad or sharp brush Radiother Oncol 100 2011 396 401
17. N. Andratschke, F. Zimmermann, and E. Boehm Stereotactic radiotherapy of histologically proven inoperable stage I non-small cell lung cancer: patterns of failure Radiother Oncol 101 2011 245 249
18. F.X. Li, J.B. Li, and Y.J. Zhang Comparison of the planning target volume based on three-dimensional CT and four-dimensional CT images of non-small cell lung cancer Radiother Oncol 99 2011 176 180
19. J. Boda-Heggemann, J. Fleckenstein, and F. Lohr Multiple breath-hold CBCT for online image guided radiotherapy of lung tumors: simulation with a dynamic phantom and first patient data Radiother Oncol 98 2011 309 316
20. R. Speight, J. Sykes, R. Lindsay, K. Frank, and D. Thwaites The evaluation of a deformable image registration segmentation technique for semi-automating internal target volume (ITV) production from 4DCT images of lung stereotactic body radiotherapy (SBRT) patients Radiother Oncol 98 2011 277 283
21. P. Vera, P. Bohn, and A. Edet-Sanson Simultaneous positron emission tomography (PET) assessment of metabolism with 18F-fluoro-2-deoxy-d-glucose(FDG) proliferation with 18F-fluoro-thymidine (FLT), and hypoxia with 18fluoro-misonidazole (F-miso) before and during radiotherapy in patients with non-small-cell lung cancer (NSCLC): a pilot study Radiother Oncol 98 2011 109 116
22. J. Jassem The role of radiotherapy in lung cancer: where is the evidence? Radiother Oncol 83 2007 203 213
23. A. Auperin, C. Le Pechoux, and E. Rolland Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer J Clin Oncol 28 2010 2181 2190
24. M. Guckenberger, K. Baier, and B. Polat Dose-response relationship for radiation-induced pneumonitis after pulmonary stereotactic body radiotherapy Radiother Oncol 97 2010 65 70
25. M. Partridge, M. Ramos, A. Sardaro, and M. Brada Dose escalation for non-small cell lung cancer: analysis and modeling of published literature Radiother Oncol 99 2011 6 11
26. C. Dehing-Oberije, D. De Ruysscher, and S. Petit Development, external validation and clinical usefulness of a practical prediction model for radiation-induced dysphagia in lung cancer patients Radiother Oncol 97 2010 455 461
27. Z.F. Zhu, M. Fan, and K.L. Wu A phase II trial of accelerated hypofractionated three-dimensional conformal radiation therapy in locally advanced non-small cell lung cancer Radiother Oncol 98 2011 301 308
28. C. Siedschlag, L. Boersma, and J. van Loon The impact of microscopic disease on the tumor control probability in non-small-cell lung cancer Radiother Oncol 100 2011 344 350
29. J.A. Bonner, C.D. Willey, and E.S. Yang Treatment of small-cell lung cancer with TRA-8 in combination with cisplatin and radiation Radiother Oncol 101 2011 183 189
30. L. Kepka, K. Bujko, and T.M. Orlowski Cardiopulmonary toxicity and quality of life in non-small cell lung cancer patients treated with or without postoperative radiotherapy Radiother Oncol 98 2011 238 243
31. P. Warde, and D. Payne Does thoracic irradiation improve survival and local control in limited stage small-cell carcinoma of the lung. A meta-analysis J Clin Oncol 10 1992 890 895
32. J.P. Pignon, R. Arriagada, and D.C. Ihde A meta-analysis of thoracic radiotherapy for small-cell lung cancer N Engl J Med 327 1992 1618 1624
33. D. De Ruysscher, M. Pijls-Johannesma, J. Vansteenkiste, A. Kester, I. Rutten, and P. Lambin Systematic review and meta-analysis of randomized, controlled trials of the timing of chest radiotherapy in patients with limited-stage, small-cell lung cancer Ann Oncol 17 2006 543 552
34. N.B. Arvidson, D. Khuntia, and W.A. Tome Dose escalation model for limited-stage small-cell lung cancer Radiother Oncol 91 2009 379 385
35. A.T. Turrisi 3rd, K. Kim, and R. Blum Twice daily compared with once daily thoracic radiotherapy in limited small cell lung cancer treated concurrently with cisplatin and etoposide N Engl J Med 340 1999 265 271
36. A. Auperin, R. Arriagada, and J.P. Pignon Prophylactic cranial irradiation for patients with small cell lung cancer in complete remission: a meta-analysis of individual data from 987 patients N Engl J Med 341 1999 476 484
37. B. Slotman, C. Faivre-Finn, and G. Kramer Prophylactic cranial irradiation in extensive small-cell lung cancer N Engl J Med 357 2007 664 672
38. B. Xia, G.-Y. Chen, and X.-W. Cai Is involved-field radiotherapy based on CT safe for patients with limited-stage small-cell lung cancer? Radiother Oncol 102 2012 258 262
39. M.E. Giuliani, P.E. Lindsay, and A. Sun Locoregional failures following thoracic irradiation in patients with limited-stage small-cell lung carcinoma Radiother Oncol 102 2012 263 267
40. D. Yee, C. Butts, and A. Reiman Clinical trial of post-chemotherapy consolidation thoracic radiotherapy for extensive-stage small cell lung cancer Radiother Oncol 102 2012 234 238
41. T. Tada, K. Minakuchi, and M. Koda Limited-stage small cell lung cancer: local failure after chemotherapy and radiation therapy Radiology 208 1998 511 515
42. M. Wierzchowski, A. Sprawka, and L. Kepka Isolated nodal failure after chemo-radiotherapy in limited disease small cell lung cancer (LD-SCLC) Rep Pract Oncol Radiother 14 2009 58 63
43. L. Kepka, K. Bujko, A. Zolciak-Siwinska, and D. Garmol Incidental irradiation of mediastinal and hilar lymph node stations during 3D-conformal radiotherapy for non-small cell lung cancer Acta Oncol 47 2008 954 961
44. D. De Ruysscher, R.H. Bremer, and F. Koppe Omission of elective nodal irradiation on basis of CT-scans in patients with limited disease small cell lung cancer: a phase II trial Radiother Oncol 80 2006 307 312
45. P. Baas, J. Belderbos, and S. Senan Concurrent chemotherapy (carboplatin, paclitaxel, etoposide) and involved-field radiotherapy in limited stage small-cell lung cancer: a Dutch multicenter phase II study Br J Cancer 94 2006 625 630
46. J. Belderbos, P. Baas, and S. Senan Reply: patterns of nodal recurrence after omission of elective nodal irradiation for limited stage small-cell lung cancer Br J Cancer 97 2007 26
47. D. De Ruysscher, and C.M. Kirsch PET scans in radiotherapy planning of lung cancer Radiother Oncol 96 2010 335 338
48. P. Lin, E.-S. Koh, and M. Lin Diagnostic and staging impact of radiotherapy planning FDG-PET-CT in non-small cell lung cancer Radiother Oncol 101 2011 284 290
49. J. Van Loon, C. Offermann, and G. Bosmans 18FDG-PET based radiation planning of mediastinal lymph nodes in limited disease small cell lung cancer changes radiotherapy fields: a planning study Radiother Oncol 87 2008 49 54
50. 18 FDG-PET scans in limited disease small cell lung cancer: a prospective study Int J Radiat Oncol Biol Phys 77 2010 329 336
51. 18 FDG-PET scans in limited disease small cell lung cancer: a prospective study. In regard to Van Loon et al. (Int J Radiat Oncol Biol Phys 2010;77:329-336). Letter to the Editor Int J Radiat Oncol Biol Phys 78 2010 1606
52. D. Yee, R. Halperin, and J. Hanson Phase I study of hypofractionated dose escalated thoracic radiotherapy for limited stage small cell lung cancer Int J Radiat Oncol Biol Phys 65 2006 466 473
53. D. Yee, J. Hanson, and C. Butts Phase I dose escalation trial of hypofractionated limited-field external beam thoracic radiotherapy for limited-stage small cell carcinoma of the lung Radiother Oncol 96 2010 26
54. G.M. Videtic, J.S. Belderbos, F.M. (Spring) Kong, L. Kepka, M.K. Martel, and B. Jeremic Report from the International Atomic Energy Agency (IAEA) consultants' meeting on elective irradiation in lung cancer: small cell lung cancer (SCLC Int J Radiat Oncol Biol Phys 72 2008 327 334
55. Concurrent ONce daily VErsus twice daily RadioTherapy: a 2 arm randomized controlled trial of concurrent chemo-radiotherapy comparing twice-daily and once-daily radiotherapy schedules in patients with limited stage small cell lung cancer (SCLC) and good performance status. Available from: http://www.christie. nhs.uk/research/themes/convert/default.aspx.2008 CONVERT
56. B. Jeremić, Y. Shibamoto, and N. Nicolić Role of radiation therapy in the combined modality treatment of patients with extensive disease small-cell lung cancer: a randomized study J Clin Oncol 17 1999 2092 2099
57. M. Puglisi, S. Dolly, A. Faria, J.S. Myerson, S. Popat, and M. O'Brien Treatment options for small cell lung cancer - do we have more choice? Br J Cancer 102 2010 629 638
58. Randomized phase II study comparing prophylactic cranial irradiation alone to prophylactic cranial irradiation and consolidative extracranial irradiation for extensive disease small cell lung cancer (ED-SCLC). Available from: www.rtog.org: RTOG 0937.
59. NTR 1527. CREST trial. Randomised trial on chest irradiation in extensive disease small cell lung cancer. Available from: www.trialregister.nl.
60. N. Hanna, P.A. Bunn Jr, and C. Langer Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small cell lung cancer J Clin Oncol 24 2006 2038 2043
61. S. Falk, D. Girling, and R. White Immediate versus delayed palliative thoracic radiotherapy in patients with unresectable locally advanced non-small cell lung cancer and minimal thoracic symptoms: randomised controlled trial Br Med J 325 2002 465 472
62. S. Sundstrom, R. Bremnes, and P. Brunswing Immediate or delayed radiotherapy in advanced non-small cell lung cancer (NSCLC)? Data from a prospective randomised study Radiother Oncol 75 2005 141 148